SCHEDULE 13G/A: HBM Healthcare Investments Discloses 8.4% Stake in ALX Oncology Holdings
Beneficial Ownership Disclosure
HBM Healthcare Investments (Cayman) Ltd. has filed an amended Schedule 13G, disclosing a beneficial ownership of 8.4% in ALX Oncology Holdings Inc. as of March 31, 2025.
Summary
- HBM Healthcare Investments (Cayman) Ltd. reported beneficial ownership of 4,500,000 shares of ALX Oncology Holdings Inc. Common Stock.
- This ownership represents approximately 8.4% of the outstanding shares of ALX Oncology Holdings Inc.
- The percentage is calculated based on 53,384,145 shares outstanding as of February 27, 2025, as reported in ALX Oncology's Annual Report on Form 10-K filed on March 6, 2025.
- HBM Healthcare Investments (Cayman) Ltd. holds sole voting power and sole dispositive power over all 4,500,000 shares.
- The filing certifies that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: Neutral. A Schedule 13G is a factual disclosure of ownership and does not inherently convey positive or negative sentiment regarding the company's performance or outlook. It simply reports a significant stake.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake, which could influence market perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 2025-02-27 | Date of shares outstanding calculation (53,384,145 shares) for ALX Oncology Holdings Inc. |
| 2025-03-06 | Date ALX Oncology Holdings Inc. filed its Annual Report on Form 10-K, reporting shares outstanding. |
| 2025-03-31 | Date of event requiring the filing of this statement (beneficial ownership calculation date). |
| 2025-05-15 | Date the Schedule 13G/A was signed by HBM Healthcare Investments (Cayman) Ltd. |
Keywords
ALX Oncology Holdings Inc., HBM Healthcare Investments, Schedule 13G, Beneficial Ownership, Common Stock, Healthcare Investments, Biotechnology, Oncology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.